Physician profile
Derek Gallucci
NPI 1346508991
$829.30
in general payments reported to CMS, 2019-2025
13 companies · $92.17 in 2025
The $92.17 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $76.65 · 2020: $127 · 2021: $114 · 2022: $205 · 2023: $36.76 · 2024: $177 · 2025: $92.17.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $306.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $306.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $193.36 | 2020-2025 | |
| Glaxosmithkline, LLC. | $147.17 | 2019-2023 | Trelegy Ellipta |
| Okami Medical, INC. | $119.97 | 2024 | Lobo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $110.33 | 2019-2022 | |
| Dexcom, INC. | $55.93 | 2023-2025 | Dexcom G6 Transmitter |
| Phathom Pharmaceuticals, INC. | $50.95 | 2024-2025 | Voquezna |
| Abbvie INC. | $41.92 | 2022-2024 | |
| Astrazeneca Pharmaceuticals Lp | $30.57 | 2020-2025 | Breztri |
| Medtronic, INC. | $25.08 | 2021 | |
| Lilly USA, LLC | $14.62 | 2020 | |
| Pfizer INC. | $14.43 | 2019 | |
| Mannkind Corporation | $12.64 | 2020 | |
| Abbott Laboratories | $12.33 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Derek Gallucci listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.